Please login to the form below

Not currently logged in
Email:
Password:

Mundipharma appoints Dr Alberto Martinez as president and CEO

He succeeds Antony Mattessich, who leaves after 12 years with the networked company

Alberto MartinezMundipharma has appointed Dr Alberto Martinez as its new president and chief executive officer, succeeding Antony Mattessich, who leaves the network after 12 years of service to pursue his career in the US.

Dr Martinez’ career has seen him gain expertise in the healthcare and pharmaceutical fields, more specifically in the strategic, financial and operational capacity.

His new role will see him take responsibility for strengthening Mundipharma’s network in Europe and focus on its alliances.

Additionally, research and development, global manufacturing, supply chain and IT functions will fall under Dr Martinez’s new remit.

He said: “I feel honoured and privileged to be given the opportunity to lead the Mundipharma organisations in Europe in the next chapter of our evolution and success. I am committed to ensure that we remain ambitious and agile so we continue to bring valuable and innovative medicines to patients and healthcare providers as a successful, diversified and forward-thinking organisation.”

Dr Martinez originally joined the Mundipharma network in 2003 and has held roles of increasing responsibility over the past 14 years.

Prior to his time at Mundipharma, he served Napp Pharmaceuticals and Janssen in various capacities.

8th January 2018

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Research Partnership

We are the largest independent healthcare market research and consulting agencies in the world. Trusted partner to the global pharmaceutical...

Latest intelligence

A uniquely English genomic medicine service
The UK National Health Service is developing one standardised approach to embedding precision medicine across the whole of England. Blue Latitude Health speaks to Dr Tom Fowler, Deputy Chief Scientist...
Blended Intelligence
Data is the most valued commodity of the modern world. For P&P it's all about the application....
The relevance of patient perspectives to value
Exploring the evolution of patient involvement in health technology assessment, and the role of the patient voice in market access....

Infographics